Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDci Advisors Regulatory News (DCI)

Share Price Information for Dci Advisors (DCI)

Share Price is delayed by 15 minutes
Get Live Data
4.50    0.00 (0.00%)
Bid:
4.30
Ask:
4.70
Spread: 0.40 (9.302%)
Market Cap: £40.71m
DCI Live PriceLast checked at - London Stock Exchange

Intraday Dci Advisors Share Chart

Director/PDMR Shareholding

13 May 2008 06:00

RNS Number : 2548U
Dolphin Capital Investors Limited
13 May 2008
 



13 May 2008

DOLPHIN CAPITAL INVESTORS LIMITED

Director's Shareholding

Dolphin Capital Investors Limited ("DCI" or the "Company") announces that Dolphin Capital Participations Limited ("DCPart"), a wholly owned subsidiary of Dolphin Capital Holdings Limited ("DCH") in turn owned 75% by Mr. Kambourides, has on 12 May 2008 charged 25,000,000 DCI common shares as security for a loan facility from Bank of Cyprus Public Company Limited ("BoC")

The loan facility can only be drawn down by DCPart should further purchases of common shares in the Company be madeThe charging of the common shares constitutes a share dealing pursuant to the AIM Rules and by dint of his interest in DCPart, a notifiable dealing by Miltos Kambourides as a director of the Company. DCPart will maintain the voting rights of the charged shares and will remain entitled to any corresponding dividends payable to the charged shares, whilst the terms of the facility are complied with.  

To allow for BoC to take a legal charge over the 25,000,000 DCI common shares, the Company and Panmure Gordon have consented to a release of the terms of the DCPart lock-up undertaking for the 25,000,000 DCI common shares. The remaining 6,535,149 DCI common shares owned by DCPart and any of the 25,000,000 common shares which are subsequently released from the legal charge to BoC will remain subject to the terms of the DCPart lock-up undertaking which expires in March 2010. The 31,535,149 shares were issued to DCPart on 25 March 2008 following the exercise of over-performance warrants. 

Following the charging of the common shares held by DCPartthe total number of common shares in the Company controlled by Miltos Kambourides which are subject to a charge has changed as follows:

 PDMR

Total number of shares controlled before notification

Total number of shares controlled following notification

Total number of shares indirectly owned before notification

Total number of shares indirectly owned following notification

Total number of charged shares before notification

Total number of shares charged to BoC after notification

Miltos Kambourides

56,824,449

56,824,449 (A)

42,618,337

42,618,337 (B)

22,090,000

47,090,000 (C)

 

Notes:

controlled shares as a result of DCH holding 3,199,300 common shares directly, 22,090,000 common shares though its wholly owned subsidiary Dolphin Capital Participations Two Limited and 31,535,149 through its wholly owned subsidiary DCPart.

indirect interest, held as a result of Mr. Kambourides holding a 75% shareholding in Dolphin Capital Holdings Limited.

common shares charged to BoC as security for BoC loan facilities where the financial and voting rights of 22,090,000 and 25,000,000 of the charged shares remain with DCPart2 and DCPart respectively whilst the terms of the corresponding facilities are complied with.

For further information, please contact:

 

Dolphin Capital Partners Limited 

Miltos Kambourides / Pierre Charalambides

miltos@dolphincp.com / pierre@dolphincp.com

 

Grant Thornton Corporate Finance Tel: +44 (0) 20 7383 5100

(Nominated Adviser)

Philip Secrett

 

Panmure Gordon Tel: +44 (0) 20 7459 3600

(Broker)

Richard Gray / Dominic Morley / Andrew Potts

 

Financial Dynamics Tel: +44 (0) 20 7831 3113

Stephanie Highett

END 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSDLLFFVEBLBBD
Date   Source Headline
30th Jun 20231:25 pmRNSAnnual Financial Report
29th Jun 20234:50 pmRNSShareholder Loans
7th Jun 20237:00 amRNSChange of Name
26th May 20232:19 pmRNSShareholder Loans
26th May 20239:41 amRNSKilada Funding
3rd May 20234:24 pmRNSHolding(s) in Company
28th Apr 20239:41 amRNSShareholder Loans
27th Apr 20232:45 pmRNSHolding(s) in Company
19th Apr 20237:00 amRNSShareholder Loans and Related Party Transaction
18th Apr 202310:30 amRNSShareholder Update
13th Apr 20234:21 pmRNSHolding(s) in Company
13th Apr 20233:58 pmRNSHolding(s) in Company
11th Apr 20234:36 pmRNSHolding(s) in Company
11th Apr 20233:12 pmRNSFiling of Claim Form
6th Apr 20234:50 pmRNSHolding(s) in Company
5th Apr 20234:39 pmRNSNew website now live
31st Mar 20236:13 pmRNSCompany Website
20th Mar 20237:00 amRNSTermination of Inv. Manager & Removal of Director
17th Feb 20233:48 pmRNSHolding(s) in Company
13th Feb 20237:00 amRNSDirectorate Change
23rd Dec 20229:07 amRNSCompletion of disposal of interest in OOKI
31st Oct 202210:24 amRNSHolding(s) in Company
28th Oct 202210:31 amRNSHolding(s) in Company
25th Oct 20222:30 pmRNSDirector/PDMR Shareholding
24th Oct 20229:11 amRNSDirector/PDMR Shareholding
21st Oct 20223:17 pmRNSDirector/PDMR Shareholding
20th Oct 202212:35 pmRNSDirector/PDMR Shareholding
19th Oct 20223:57 pmRNSDirector/PDMR Shareholding
18th Oct 202212:09 pmRNSResult of AGM
30th Sep 20228:46 amRNSHalf-year Report
29th Sep 20223:23 pmRNSDisposal of One&Only at Kea Island project
16th Sep 20224:41 pmRNSSecond Price Monitoring Extn
16th Sep 20224:36 pmRNSPrice Monitoring Extension
14th Sep 20224:15 pmRNSNotice of AGM
30th Jun 20229:42 amRNSAnnual Financial Report
22nd Jun 20223:52 pmRNSHolding(s) in Company
16th May 202212:18 pmRNSShareholder Communications Letter
22nd Dec 202112:09 pmRNSResult of Extraordinary General Meeting
2nd Dec 20217:00 amRNSNotice of EGM
26th Nov 20217:00 amRNSChange of Adviser
27th Sep 20217:00 amRNSHalf Year Results and Trading Update
19th Jul 20217:50 amRNSDrawdown of 2nd tranche of EUR15m loan facility
19th Jul 20217:00 amRNSDrawdown of 2nd tranche of EUR15m loan facility
1st Jul 20217:05 amRNSGovernance Changes and Strategic Review
1st Jul 20217:00 amRNSDirectorate Changes
30th Jun 20217:00 amRNSAnnual Financial Report
7th Jun 20217:00 amRNSFinal Results
6th May 20212:26 pmRNSHolding(s) in Company
31st Mar 202111:52 amRNSHolding(s) in Company
5th Mar 20217:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.